Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-02-26 @ 4:18 PM
Study NCT ID:
NCT01143402
Status:
COMPLETED
Last Update Posted:
2017-07-26
First Post:
2010-06-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06
Start Date Type:
None
Primary Completion Date:
2016-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05
Completion Date Type:
ACTUAL
First Submit Date:
2010-06-11
First Submit QC Date:
None
Study First Post Date:
2010-06-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-07
Results First Submit QC Date:
None
Results First Post Date:
2017-05-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-26
Last Update Post Date:
2017-07-26
Last Update Post Date Type:
ACTUAL